chrisvoncsefalvay/vaers-outcomes huggingface dataset:
and pain down to the foot, ankle and calf areas, after second vaccine; Headache: left side and right side of head, frontal area, feels like it is travelling from her arm to her head, after the second vaccine; Face spasms on the left side of face; after the second vaccine and it was worsened; Chills, after first and second vaccine; Injection site sore after first and second vaccine; Arm was numb, tingley and painful from the shoulder to the fingertips after first and second dose; Left side of the body had tingling, numbness; This is a spontaneous report from female contactable consumer (Patient). A 76-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection, lot number was not reported) via unspecified route of administration, administered in left arm on 31Mar2021 at 14:00 (at the age of 76-years-old) as single dose for COVID-19 immunization. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Batch/Lot number: EN6204) via unspecified route of administration in left arm on 03Mar2021 at 14:00 as single dose for COVID-19 immunization and on same day patient experienced outbreak, looked like hives, on her torso and stomach area, chills, injection site sore (which subsided after 18-days), arm was numb, tingley and painful from the shoulder to the fingertips. Medical History and concomitant medications were not reported. No additional vaccines administered on same date of the Pfizer suspect. No vaccinations within 4 weeks prior vaccinations. On 31Mar2021 (same day of 2nd dose of vaccination), patient experienced face spasms on the left side of face, after the second vaccine which was intermittent in the evening, headache: left side and right side of head, frontal area, feels like it is travelling from her arm to her head and left side of the body had tingling, numbness and pain down to the foot, ankle and calf areas, along with the events of first dose, which were worsened after second dose that included chills and injection site sore (which subsided 18-days after first dose), arm was numb, tingley and painful from the shoulder to the fingertips. Patient required to visit physician office, primary care doctor for her numbness, tingling and pain. Reporter stated she was very interested in percentages in age groups who have experienced any numbness and tingling and asked if there are any correlation with developing blood clots and would like the information to see if she needs further medical attention and to prevent a serious outcome and discuss it with her doctor and agrees to be transferred to Medical Information. The outcome of all the events was not recovered.  No follow-up attempts are needed. No further information is expected.
pt recv vax 25FEB94 & 28FEB94 pt devel fine papular rash on face & neck; pt recovered p/3 or 4 days; rash was caused by make-up; 2nd vax given w/no incident;
Pt developed hives and "tight chest" the evening after receiving vaccine. Pt complained of itching once hives developed. Pt has history of asthma.
This spontaneous report was received from a licensed practical nurse referring to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories. On unknown dates since 24-APR-2017, the patients were vaccinated with improperly stored doses of VARIVAX (lot number M040137 with expiration date of 28-SEP-2018, lot number M038858 with expiration date of 14-SEP-2018, lot number M028551 with expiration date of 07JUN-2018 and lot number M027342 with expiration date of 01-JUN-2018; strength, dose, route and anatomical location were not provided), for prophylaxis. It was also reported that the administered doses experienced a temperature excursion during 15 minutes at a temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit on unspecified dates, and a temperature excursion during 1 hour 54 minutes at a temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit on unspecified dates. No previous temperature excursion was reported. A data logger issue was involved. No adverse experiences were reported. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1705USA009207:
Unusual and severe menstrual cycle. Very heavy and lasted over a week. Bled through super tampons within an hour for first four days. I am usually very regular and predictable. I never had a menstrual cycle this bad in my entire life.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 04-FEB-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength 0.5 mL, lot # L027282, expiration date 21-SEP-2017, dose and route were unknown). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion four times. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the first excursion was 56, 33 and R. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the second excursion was 24, 31 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the third excursion was 24, 48 and R.  The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the fourth excursion was 120, 29 and R. This is one of several reports received from the same source. Additional information has been requested.
I was diagnosed with breast cancer on 10/11/2021 with a routine mammogram. They did several types of Biopsies and MRIs. I had DCIS stage 0. I had a Lumpectomy and radiation. I also take a new medication to help prevent it, it is called Tamoxifen. I still have an open wound that got infected a couple of weeks ago. They had to drained it. I had home health until the end of February.
The injection site started to itch on the entire shoulder area. It was red and hot to touch. It lasted all day and little the following day
Swollen lymph nodes and pain near the thyroid gland. Pain in the left side of the neck area, and difficulty talking.
3 days of constant headaches, myalgias, fatigue and nausea, mild diarrhea
Received second vaccination in  left arm. Following the vaccination arm was sore, but not to bad. However, as the day went on into the evening she felt as though her shoulder was impinged. The pain is still there today and intensifies with movement. It is a sharp pain in the shoulder blade area that radiates up her shoulder into the left side of her  collarbone area (both anteriorly and posteriorly) and up into her neck as well as down to  elbow.
Client called and reported she experienced scatchy throat, and a hoarse voice 30 minutes after injecction. Then started to feel week, dizzy and had to leave work. She then had left shoulder pain and aching, along with swollen lymph nodes. These symptoms have now persisted for over 2 weeks. Advised client to follow-up with doctor, client denies any respiratory or other symptoms
This spontaneous report was received from a health care worker regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On 29-DEC-2015, the patient was vaccinated with an improperly stored dose of ROTATEQ (orally, dose was not reported, lot # L013188, expiration date 02-NOV-2016). There was no adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Mom called 9/1/2021 stating that patient was experiencing hives and itching on his chest and back post COVID 1st dose. She said that at the time he had a bright red welt at vaccine site.
This spontaneous report as received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 24-JAN-2019, the patient was vaccinated with expired dose of M-M-R II for prophylaxis (dose, strength, route of administration , lot # were not reported, expiration date 22-JAN-2019). The reporter stated that the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) did not have any temperature excursions prior to administration. No adverse symptoms were reported.  The outcome of the events was unknown. Causality assessment was not provided.
My right ankle becomes swollen after i receive the vaccine; This is a spontaneous report from a contactable consumer or other non hcp.   A 49-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No was not reported), via an unspecified route of administration on 05May2021 as 2nddose, single for covid-19 immunisation.             (Age at Vaccination was 49 years). Historical vaccine was A 49-years-old female patient received BNT162b2 (CONMINTARY, Solution for injection, Lot No was not reported), via an unspecified route of administration on unspecified date as 1st dose, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced my right ankle becomes swollen after i receive the vaccine on 05May2021.  The patient underwent lab tests and procedures which included ultrasound scan: unknown results   on   i got two ultrasounds of my leg, x-ray: unknown results   on   an x-ray of my knee. Upon follow-up 31Jul2021 is a follow-up spontaneous report from a contactable consumer. This 49-year-old consumer (patient) reported for herself about transcription analysis my right ankle became swollen after I received the vaccine my doctor doesn't know why my ankle is swelling i got two ultrasounds of my leg and an x-ray of my knee and there's they still don't know why my ankle was swollen. Outcome of the event was unknown. Follow-up 31Jul2021 is a follow-up spontaneous report from a contactable consumer. This 49-year-old consumer (patient) reported for herself about transcription analysis my right ankle became swollen after I received the vaccine my doctor doesn't know why my ankle is swelling i got two ultrasounds of my leg and an x-ray of my knee and there's they still don't know why my ankle was swollen. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Varicella - Information has been received from a registered nurse concerning a 4 year old female patient who on 11 Jul 1996 was vaccinated with varicella virus vaccine live.  On 20 Mar 2000 the patient broke out in a mild form of chickenopox.  it was noted that the patient was afebrile and only a few lesions were present.  Unspecified medical attention was sought.  no further information is available.
40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (40 doses of Moderna Bivalent vaccine about 10 days beyond use by date to adult patients).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-698650 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-698650:Master
Arm soreness and swelling, fever of 101.2, aches, fatigue, neck soreness, headache/
Patient's right upper arm became very sore later that evening and then became red, hot and swollen. The entire upper arm was swollen. She also experienced chills and a low grade fever. Two days later, she still has a red band around her upper right arm. No treament-advised to see MD.
Patient reported that he was having stomach pain and dark stools a few days after receiving the vaccination and went to the doctor's office  and they said he had a GI bleed.
Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022; Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A, 035C21A, 007C21A and 038B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022) and PRODUCT STORAGE ERROR (Vial stored in refrigerator on 11-Jan-2022 and administered to the patient on 04-May-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was reported by pharmacist, the vaccine coordinator in their health care facility, that they inadvertently administered an expired dose of the Moderna Covid-19. Post further investigation of the issue, pharmacist identified an additional issue that staff were not dating the boxes of vaccine when placing them in the fridge for storage. This lot number 084J21A was received and placed in the fridge initially on 11-Jan-2022, which means that all doses administered more than 30 days after 11-Jan-2022 were not in accordance. The vial did not undergo any temperature excursions. The patient did not report any adverse reaction to the health care professional's knowledge.  No treatment medication was reported.
5 1/2 cm inuration & bright reddness of lt outer thigh 15 cm reddness, erythema present vesicular rash @ area of outer induration; no generalized sx-afebrile;
Information has been received from a registered nurse concerning a 6 year old female who on 04/13/1999 was vaccinated subcutaneously with a dose of varicella virus vaccine live.  On 02/09/2005 the patient developed chickenpox with over 50 pox counted per Mom.  At the time of the report the patient's outcome was unknown.  Additional information is not expected.
Upon receiving booster of J/J after initial with Pfizer Woke up 12 hours after with chills, uncontrollable shaking, Sever back pain, and fever of 101.2 Treatment was 600mg of Ibuprofen - little relief
Pt c/o sore neck on the right side. Limited ROM. Pt was given seasonal influenza 0.5 ml injection on the right side and H1N1 0.5 ml injection on the left side.
1 of 4 adults vaxed on 9NOV94;pt exp swelling & itching following vax;not seen by MD;recovered;
This spontaneous report was received from a licensed practical nurse (L.P.N) via a telephone call, concerning a 4 year old male patient. No concurrent conditions or medical history were reported. On 22-APR-2015, the patient was vaccinated with an improperly stored dose of (Oka-Merck) PROQUAD (Lot # K018142 Expiration date: 10-APR-2016) (dose, frequency and anatomical location of administration were not reported). No concomitant therapies or adverse experiences were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
CDC reports: 1 yo child developed fever to 105, convuls & vomiting which continued 2 hrs p/receiving DTP/OPV/HIB immunization. Also had hypotonic episode. Hospitalized 2 days.
nauseated; vomiting for 4 hours; strong metal taste in my mouth; got very weak; couldn't move; no appetite; This spontaneous case was reported by a physical therapist and describes the occurrence of TASTE DISORDER (strong metal taste in my mouth), ASTHENIA (got very weak), MOVEMENT DISORDER (couldn't move), DECREASED APPETITE (no appetite) and NAUSEA (nauseated) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history not provided.  The patient's past medical history included No adverse event. Concomitant products included lisnopril for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced TASTE DISORDER (strong metal taste in my mouth), ASTHENIA (got very weak), MOVEMENT DISORDER (couldn't move), DECREASED APPETITE (no appetite) and VOMITING (vomiting for 4 hours). On 25-Feb-2021, the patient experienced NAUSEA (nauseated). At the time of the report, TASTE DISORDER (strong metal taste in my mouth), ASTHENIA (got very weak), MOVEMENT DISORDER (couldn't move), DECREASED APPETITE (no appetite) and NAUSEA (nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: Concomitant products included LISINOPRIL and CARVEDILOL (coreg) for unknown indication.
The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years; The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years), COVID-19 IMMUNISATION (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years) and NO ADVERSE EVENT (No adverse event) in a 4-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer-BioNTech vaccine (Dose 2) and Pfizer-BioNTech vaccine (Dose 1). Past adverse reactions to the above products included No adverse event with Pfizer-BioNTech vaccine and Pfizer-BioNTech vaccine.    On an unknown date, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years), COVID-19 IMMUNISATION (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years) and NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years), COVID-19 IMMUNISATION (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years) and COVID-19 IMMUNISATION (The patient got the Moderna Bivalent 6 months to 4 years instead of the Pfizer bivalent 6 months to 4 years).    No relevant concomitant medications were reported.  No treatment information was provided.
On 3/12/21 day of injection  The patient got the Johnson & Johnson Covid vaccine this afternoon around 1400, after which he noted a red, itchy rash on his chest, back, and bilateral upper extremities. He also notes a dry mouth and mild throat swelling, but denies shortness of breath, vomiting, lightheadedness, chest pain.  He took benadryl about an hour  after getting the vaccine without any improvement.. He states that amoxicillin is the only medication to which has had an allergic reaction.   On 3/12/21 He was s treated with Vistaril 50 mg, Deltasone 50 mg, and epinephrine 0.3 mL.  The medications relieve most of his symptoms for 2 hours before it returned along with having developed a sore throat and sensation of swelling to his throat.  On 3/13/21 at 0139am  patient returned to ED for further evaluation. Patient remedicated with benadryl, epinephrine and was given pepcid.  On 3/14/21 at 1430 patient again seen in ED for further evaluation with worsening rash. patient that last night he had a severe allergic reaction and self administered epinephrine at 0440. This morning he woke up with a worsening rash that he describes as burning. He reports a sensation of throat swelling. He has had 3 episodes of diarrhea, but no nausea or vomiting. Yesterday, patient states that his heart was "racing" but denies any chest pain. He states that every time his rash is treated, it returns and is worse in severity